Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1993 Oct;70(4):304–306. doi: 10.1136/hrt.70.4.304

Antiarrhythmic drugs in the management of atrial fibrillation.

J C Cowan
PMCID: PMC1025324  PMID: 8217437

Full text

PDF
304

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ang E. L., Chan W. L., Cleland J. G., Moore D., Krikler S. J., Alexander N. D., Oakley C. M. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation. Br Heart J. 1990 Oct;64(4):256–260. doi: 10.1136/hrt.64.4.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atwood J. E., Sullivan M., Forbes S., Myers J., Pewen W., Olson H. G., Froelicher V. F. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. J Am Coll Cardiol. 1987 Aug;10(2):314–320. doi: 10.1016/s0735-1097(87)80013-x. [DOI] [PubMed] [Google Scholar]
  3. Bourke J. P., Cowan J. C., Tansuphaswadikul S., Campbell R. W. Antiarrhythmic drug effects on left ventricular performance. Eur Heart J. 1987 Mar;8 (Suppl A):105–111. doi: 10.1093/eurheartj/8.suppl_a.105. [DOI] [PubMed] [Google Scholar]
  4. Cowan J. C., Gardiner P., Reid D. S., Newell D. J., Campbell R. W. A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction. J Cardiovasc Pharmacol. 1986 Mar-Apr;8(2):252–256. doi: 10.1097/00005344-198603000-00005. [DOI] [PubMed] [Google Scholar]
  5. Crijns H. J., Van Gelder I. C., Van Gilst W. H., Hillege H., Gosselink A. M., Lie K. I. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol. 1991 Aug 1;68(4):335–341. doi: 10.1016/0002-9149(91)90828-9. [DOI] [PubMed] [Google Scholar]
  6. DiBianco R., Morganroth J., Freitag J. A., Ronan J. A., Jr, Lindgren K. M., Donohue D. J., Larca L. J., Chadda K. D., Olukotun A. Y. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin. Am Heart J. 1984 Oct;108(4 Pt 2):1121–1127. doi: 10.1016/0002-8703(84)90592-1. [DOI] [PubMed] [Google Scholar]
  7. Donovan K. D., Dobb G. J., Coombs L. J., Lee K. Y., Weekes J. N., Murdock C. J., Clarke G. M. Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide. Am J Cardiol. 1991 Jan 15;67(2):137–141. doi: 10.1016/0002-9149(91)90435-n. [DOI] [PubMed] [Google Scholar]
  8. Falk R. H. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med. 1989 Jul 15;111(2):107–111. doi: 10.7326/0003-4819-111-2-107. [DOI] [PubMed] [Google Scholar]
  9. Falk R. H., Knowlton A. A., Bernard S. A., Gotlieb N. E., Battinelli N. J. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial. Ann Intern Med. 1987 Apr;106(4):503–506. doi: 10.7326/0003-4819-106-4-503. [DOI] [PubMed] [Google Scholar]
  10. Faniel R., Schoenfeld P. Efficacy of i.v. amiodarone in converting rapid atrial fibrillation and flutter to sinus rhythm in intensive care patients. Eur Heart J. 1983 Mar;4(3):180–185. doi: 10.1093/oxfordjournals.eurheartj.a061437. [DOI] [PubMed] [Google Scholar]
  11. Feld G. K., Chen P. S., Nicod P., Fleck R. P., Meyer D. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs. Am J Cardiol. 1990 Aug 1;66(3):378–383. doi: 10.1016/0002-9149(90)90856-v. [DOI] [PubMed] [Google Scholar]
  12. Flaker G. C., Blackshear J. L., McBride R., Kronmal R. A., Halperin J. L., Hart R. G. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 1992 Sep;20(3):527–532. doi: 10.1016/0735-1097(92)90003-6. [DOI] [PubMed] [Google Scholar]
  13. Gosselink A. T., Crijns H. J., Van Gelder I. C., Hillige H., Wiesfeld A. C., Lie K. I. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA. 1992 Jun 24;267(24):3289–3293. [PubMed] [Google Scholar]
  14. Juul-Möller S., Edvardsson N., Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation. 1990 Dec;82(6):1932–1939. doi: 10.1161/01.cir.82.6.1932. [DOI] [PubMed] [Google Scholar]
  15. Marcus F. I. The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation. Am J Cardiol. 1990 Aug 1;66(3):366–367. doi: 10.1016/0002-9149(90)90851-q. [DOI] [PubMed] [Google Scholar]
  16. McKibbin J. K., Pocock W. A., Barlow J. B., Millar R. N., Obel I. W. Sotalol, hypokalaemia, syncope, and torsade de pointes. Br Heart J. 1984 Feb;51(2):157–162. doi: 10.1136/hrt.51.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Middlekauff H. R., Wiener I., Saxon L. A., Stevenson W. G. Low-dose amiodarone for atrial fibrillation: time for a prospective study? Ann Intern Med. 1992 Jun 15;116(12 Pt 1):1017–1020. doi: 10.7326/0003-4819-116-12-1017. [DOI] [PubMed] [Google Scholar]
  18. Molajo A. O., Coupe M. O., Bennett D. H. Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. Br Heart J. 1984 Oct;52(4):392–395. doi: 10.1136/hrt.52.4.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nathan A. W., Camm A. J., Bexton R. S., Hellestrand K. J. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias. Clin Cardiol. 1987 May;10(5):317–322. doi: 10.1002/clc.4960100505. [DOI] [PubMed] [Google Scholar]
  20. Noc M., Stajer D., Horvat M. Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. Am J Cardiol. 1990 Mar 1;65(9):679–680. doi: 10.1016/0002-9149(90)91053-9. [DOI] [PubMed] [Google Scholar]
  21. Nolan J., Bloomfield P. Non-rheumatic atrial fibrillation: warfarin or aspirin for all? Br Heart J. 1992 Dec;68(6):544–548. doi: 10.1136/hrt.68.12.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Peters K. G., Kienzle M. G. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med. 1988 Aug;85(2):242–244. doi: 10.1016/s0002-9343(88)80352-8. [DOI] [PubMed] [Google Scholar]
  23. Pritchett E. L., McCarthy E. A., Wilkinson W. E. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med. 1991 Apr 1;114(7):539–544. doi: 10.7326/0003-4819-114-7-539. [DOI] [PubMed] [Google Scholar]
  24. Pritchett E. L., Wilkinson W. E. Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias. Am J Cardiol. 1991 May 1;67(11):976–980. doi: 10.1016/0002-9149(91)90170-p. [DOI] [PubMed] [Google Scholar]
  25. Rawles J. M., Metcalfe M. J., Jennings K. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br Heart J. 1990 Apr;63(4):225–227. doi: 10.1136/hrt.63.4.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rotmensch H. H., Belhassen B. Amiodarone in the management of cardiac arrhythmias: current concepts. Med Clin North Am. 1988 Mar;72(2):321–358. doi: 10.1016/s0025-7125(16)30773-8. [DOI] [PubMed] [Google Scholar]
  27. Suttorp M. J., Kingma J. H., Jessurun E. R., Lie-A-Huen L., van Hemel N. M., Lie K. I. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol. 1990 Dec;16(7):1722–1727. doi: 10.1016/0735-1097(90)90326-k. [DOI] [PubMed] [Google Scholar]
  28. Wirtzfeld A., Schmidt G., Himmler F. C., Stangl K. Physiological pacing: present status and future developments. Pacing Clin Electrophysiol. 1987 Jan;10(1 Pt 1):41–57. doi: 10.1111/j.1540-8159.1987.tb05923.x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES